In addition, proliferation of breast cancer is enhanced by insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF), which stimulate signaling through the MAPK and PI3K/AKT pathways by activation of IGF-1R and EGFR receptors, respectively. Here, AKT1 is linked to breast carcinoma.